Literature DB >> 18701655

Dynamics of the mucosa-associated flora in ulcerative colitis patients during remission and clinical relapse.

Stephan J Ott1, Sophie Plamondon, Ailsa Hart, Alexander Begun, Ateequr Rehman, Michael A Kamm, Stefan Schreiber.   

Abstract

The colonic mucosa-associated flora (MAF) in patients with active ulcerative colitis (UC) (n = 13) was investigated by examining 16S rRNA gene signatures during remission and relapse against levels for controls (n = 5). Baseline reduction, temporal instability, and decrease of bacterial richness toward relapse were observed for UC patients, whereas the MAF for controls was stable over time.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18701655      PMCID： PMC2566070          DOI： 10.1128/JCM.01512-08

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  12 in total

1.  In vitro alterations of intestinal bacterial microbiota in fecal samples during storage.

Authors:  Stephan J Ott; Meike Musfeldt; Kenneth N Timmis; Jochen Hampe; Dirk F Wenderoth; Stefan Schreiber
Journal:  Diagn Microbiol Infect Dis       Date:  2004-12       Impact factor: 2.803

2.  Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach.

Authors:  C Manichanh; L Rigottier-Gois; E Bonnaud; K Gloux; E Pelletier; L Frangeul; R Nalin; C Jarrin; P Chardon; P Marteau; J Roca; J Dore
Journal:  Gut       Date:  2005-09-27       Impact factor: 23.059

3.  Application of nonlinear analysis methods for identifying relationships between microbial community structure and groundwater geochemistry.

Authors:  Jack C Schryver; Craig C Brandt; Susan M Pfiffner; Anthony V Palumbo; Aaron D Peacock; David C White; James P McKinley; Philip E Long
Journal:  Microb Ecol       Date:  2006-01-31       Impact factor: 4.552

4.  Human colonic biota studied by ribosomal DNA sequence analysis.

Authors:  K H Wilson; R B Blitchington
Journal:  Appl Environ Microbiol       Date:  1996-07       Impact factor: 4.792

5.  Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study.

Authors:  K W Schroeder; W J Tremaine; D M Ilstrup
Journal:  N Engl J Med       Date:  1987-12-24       Impact factor: 91.245

6.  Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease.

Authors:  S J Ott; M Musfeldt; D F Wenderoth; J Hampe; O Brant; U R Fölsch; K N Timmis; S Schreiber
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

7.  Quantification of intestinal bacterial populations by real-time PCR with a universal primer set and minor groove binder probes: a global approach to the enteric flora.

Authors:  Stephan J Ott; Meike Musfeldt; Uwe Ullmann; Jochen Hampe; Stefan Schreiber
Journal:  J Clin Microbiol       Date:  2004-06       Impact factor: 5.948

8.  Mucosa-associated bacteria in the human gastrointestinal tract are uniformly distributed along the colon and differ from the community recovered from feces.

Authors:  Erwin G Zoetendal; Atte von Wright; Terttu Vilpponen-Salmela; Kaouther Ben-Amor; Antoon D L Akkermans; Willem M de Vos
Journal:  Appl Environ Microbiol       Date:  2002-07       Impact factor: 4.792

Review 9.  The role of the gut flora in health and disease, and its modification as therapy.

Authors:  A L Hart; A J Stagg; M Frame; H Graffner; H Glise; P Falk; M A Kamm
Journal:  Aliment Pharmacol Ther       Date:  2002-08       Impact factor: 8.171

10.  Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon.

Authors:  P Seksik; L Rigottier-Gois; G Gramet; M Sutren; P Pochart; P Marteau; R Jian; J Doré
Journal:  Gut       Date:  2003-02       Impact factor: 23.059
View more
  32 in total

1.  Real-time analysis of mucosal flora in patients with inflammatory bowel disease in India.

Authors:  Ravi Verma; Anil Kumar Verma; Vineet Ahuja; Jaishree Paul
Journal:  J Clin Microbiol       Date:  2010-09-22       Impact factor: 5.948

2.  Inulin-type fructans improve active ulcerative colitis associated with microbiota changes and increased short-chain fatty acids levels.

Authors:  Rosica Valcheva; Petya Koleva; Inés Martínez; Jens Walter; Michael G Gänzle; Levinus A Dieleman
Journal:  Gut Microbes       Date:  2018-11-05

Review 3.  Faecalibacterium prausnitzii: from microbiology to diagnostics and prognostics.

Authors:  Mireia Lopez-Siles; Sylvia H Duncan; L Jesús Garcia-Gil; Margarita Martinez-Medina
Journal:  ISME J       Date:  2017-01-03       Impact factor: 10.302

4.  Probiotics and ileitis: could augmentation of TNF/NFκB activity be the answer?

Authors:  Christian Jobin
Journal:  Gut Microbes       Date:  2010-05-26

5.  Dynamic changes of the luminal and mucosa-associated gut microbiota during and after antibiotic therapy with paromomycin.

Authors:  Femke-Anouska Heinsen; Henrik Knecht; Sven C Neulinger; Ruth A Schmitz; Carolin Knecht; Tanja Kühbacher; Philip C Rosenstiel; Stefan Schreiber; Anette K Friedrichs; Stephan J Ott
Journal:  Gut Microbes       Date:  2015-07-04

6.  Commensal Bacteroides species induce colitis in host-genotype-specific fashion in a mouse model of inflammatory bowel disease.

Authors:  Seth M Bloom; Vinieth N Bijanki; Gerardo M Nava; Lulu Sun; Nicole P Malvin; David L Donermeyer; W Michael Dunne; Paul M Allen; Thaddeus S Stappenbeck
Journal:  Cell Host Microbe       Date:  2011-05-19       Impact factor: 21.023

7.  A member of the gut mycobiota modulates host purine metabolism exacerbating colitis in mice.

Authors:  Tyson R Chiaro; Ray Soto; W Zac Stephens; Jason L Kubinak; Charisse Petersen; Lasha Gogokhia; Rickesha Bell; Julio C Delgado; James Cox; Warren Voth; Jessica Brown; David J Stillman; Ryan M O'Connell; Anne E Tebo; June L Round
Journal:  Sci Transl Med       Date:  2017-03-08       Impact factor: 17.956

Review 8.  Gene-environment interactions in inflammatory bowel disease: microbiota and genes.

Authors:  Marian C Aldhous
Journal:  Frontline Gastroenterol       Date:  2012-05-21

Review 9.  Commensal bacteria, traditional and opportunistic pathogens, dysbiosis and bacterial killing in inflammatory bowel diseases.

Authors:  Christopher D Packey; R Balfour Sartor
Journal:  Curr Opin Infect Dis       Date:  2009-06       Impact factor: 4.915

Review 10.  Gut microbiome diversity in acute infective and chronic inflammatory gastrointestinal diseases in North India.

Authors:  Saurabh Kedia; Ritika Rampal; Jaishree Paul; Vineet Ahuja
Journal:  J Gastroenterol       Date:  2016-03-19       Impact factor: 7.527
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.